HBSAG SEROCOVERSION UNDER LAMIVUDINE IN HBEAG-NEGATIVE CHRONIC HEPATITIS B

被引：0
|
作者：
Seven, Gulseren
Idilman, Ramazan
Bozkus, Yusuf
Cinar, Kubilay
Kabacam, Gokhan
Yakut, Mustafa
Bozdayi, A. Mithat [1 ]
Yurdaydin, Cihan [1 ]
机构：
[1] Ankara Univ, Fac Med, Inst Hepatol, TR-06100 Ankara, Turkey
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
453
引用
收藏
页码：545A / 546A
页数：2
相关论文
共 50 条
  • [21] Comparison of Serum Hepatitis B Virus DNA and HBsAg Levels Between HBeAg-Negative and HBeAg-Positive Chronic Hepatitis B Patients
    Keshvari, Maryam
    Alavian, Seyed Moayed
    Sharafi, Heidar
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2015, 8 (03)
  • [22] Efficacy of the treatment of HBeAg-negative chronic hepatitis B patients with lamivudine: Results of 12 month therapy
    Seliverstova, T
    Isakov, V
    Bogomolov, P
    Mironova, O
    Pavlova, T
    Tsodikov, G
    Guschin, A
    HEPATOLOGY, 2002, 36 (04) : 637A - 637A
  • [23] Significant reduction of HBsAg in the sera of HBeAg-negative chronic hepatitis B patients treated with peginterferon alfa-2A alone or in combination with lamivudine
    Brunetto, Maurizia
    Bonino, Ferruccio
    Moriconi, Francesco
    Patrick, Marcellin
    George, Lau K.
    Patrizia, Farci
    Yurdaydin, Cihan
    Piratvisuth, Teerha
    Luo, Kangxian
    Wang, Yuming
    Hadziyannis, Stephanos
    Wolf, Eva
    Matei, Popescu
    HEPATOLOGY, 2006, 44 (04) : 549A - 549A
  • [24] Predicting response to peginterferon α-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B
    Bonino, F.
    Marcellin, P.
    Lau, G. K. K.
    Hadziyannis, S.
    Jin, R.
    Piratvisuth, T.
    Germanidis, G.
    Yurdaydin, C.
    Diago, M.
    Gurel, S.
    Lai, M-Y
    Brunetto, M. R.
    Farci, P.
    Popescu, M.
    McCloud, P.
    GUT, 2007, 56 (05) : 699 - 705
  • [25] HBsAg Kinetics Prior to HBsAg Loss after Cessation of Entecavir Therapy in Hbeag-Negative Chronic Hepatitis B Patients
    Jeng, Wen-Juei
    Chang, Ming-Ling
    Liaw, Yun-Fan
    HEPATOLOGY, 2018, 68 : 272A - 272A
  • [26] Are Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B and HBeAg-Negative Chronic Hepatitis B Distinct Diseases?
    Nguyen, Mindie H.
    Keeffe, Emmet B.
    CLINICAL INFECTIOUS DISEASES, 2008, 47 (10) : 1312 - 1314
  • [27] Pretreatment HBsAg serum levels predict HBsAg seroconversion in HBeAg-negative chronic hepatitis B (CHBe-) patients
    Manesis, EK
    Hadziyannis, ES
    Angelopoulou, OP
    Hadziyannis, SJ
    HEPATOLOGY, 2005, 42 (04) : 590A - 590A
  • [28] Treatment of HBeAg-negative chronic hepatitis B with pegylated interferon
    Lampertico, Pietro
    Vigano, Mauro
    Colombo, Massimo
    LIVER INTERNATIONAL, 2011, 31 : 90 - 94
  • [29] HBsAg loss is not an ideal indicator for discontinuing treatment of HBeAg-negative chronic hepatitis B: a case report
    Dong, Pei-ling
    Zhang, Xin
    Zhao, Wen-min
    Ding, Hui-guo
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2013, 19 (06) : 1188 - 1192
  • [30] Adefovir and lamivudine combination therapy is superior to adefovir monotherapy for lamivudine-resistant patients with HBeAg-negative chronic hepatitis B
    Lampertico, Pietro
    Marzano, Alfredo
    Levrero, Massimo
    Santantonio, Teresa
    Di Marco, Vito
    Brunetto, Maurizia
    Andreone, Pietro
    Sagnelli, Evangelista
    Fagiuoli, Stefano
    Mazzella, Giuseppe
    Raimondo, Giovanni
    Gaeta, Giovannibattista
    Ascione, Antonio
    HEPATOLOGY, 2006, 44 (04) : 693A - 694A
12345